Davina went on HRT eight years ago (Picture: WireImage) Davina McCall has revealed shes still taking hormone replacement therapy (HRT) eight years after starting the perimenopause. The TV presenter, 52, started HRT when she began experiencing symptoms like severe night sweats. Speaking to Sunday Mirrors Notebook magazine, she said: Literally the first time I put the little magic sticker on I slept through the night. Continue reading →

Uncategorized By: Arianna Sholes-Douglas | 12 hours ago When Gwyneth Paltrows Netflix show Goop Lab debuted a few months ago, it garnered plenty of media hate for its pseudoscience and self-promotion. But theres one important bright spot in the show we should all pay attention to: 90-year-old sex educator Betty Dobson offering advice on sensuality. Continue reading →

Results of the National Resident Matching Program will be released on March 20. As Match Day drew near, Margaret Miller, student member of the AAFP Board of Directors and a fourth-year medical student at East Tennessee State University's Quillen College of Medicine, met with Kelly Thibert, D.O., M.P.H., resident member of the Board and a third-year resident at the Grant Family Medicine Residency at the OhioHealth Grant Medical Center, to discuss their respective Match experiences. We're sharing their conversation below for the benefit of others awaiting Match results this week, as well as medical students who will participate in the process in the future Continue reading →

Hormone Replacement Therapy Market 2020 Global Industry Research report presents an in-depth analysis of the Hormone Replacement Therapy market size, growth, share, segments, manufacturers, and technologies, key trends, market drivers, challenges, standardization, deployment models, opportunities, future roadmap and 2027 forecast. Global Hormone Replacement Therapy Market 2020 Industry Research Report is an expert and inside and out examination on the flow condition of the Global Hormone Replacement Therapy industry. Continue reading →

The increase in Market Size is a direct consequence of increasing prevalent population of Vasomotor Symptoms patients in the 7MM, along with this emerging market focus on the targeted therapies, among which NK1/3 antagonist is the most hopeful target that is likely to shift the market LAS VEGAS , March 16, 2020 /PRNewswire/ -- DelveInsight has announced the addition of a new market research report on "Vasomotor symptoms (Hot flashes/Night sweats) Market Insights, Epidemiology and Market Forecast-2030" to its offerings. The report proffers in-depth Vasomotor symptoms Market Analysis, 11 years Market Size Forecast, detailed Epidemiology analysis and 11-year Forecast, Emerging Drugs Market Uptake and information related to Leading Companies along with the Competitive Analysis edge. Continue reading →